Supernus Pharmaceuticals (SUPN) Insider Trading & Ownership $41.34 -0.13 (-0.30%) As of 03:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Supernus Pharmaceuticals (NASDAQ:SUPN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$6.10M Get SUPN Insider Trade Alerts Want to know when executives and insiders are buying or selling Supernus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SUPN Insider Buying and Selling by Quarter Supernus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/24/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$32.70$1,001 - $15,0002/21/2025Jonathan RubinSVPSell927$39.15$36,292.05 2/4/2025Padmanabh P BhattVPSell9,477$39.70$376,236.90 1/28/2025Padmanabh P BhattVPSell700$39.62$27,734.00 11/7/2024Frank MottolaSVPSell15,000$36.98$554,700.00 11/7/2024Georges GemayelDirectorSell14,213$36.62$520,480.06 11/7/2024Jack A KhattarCEOSell125,000$36.68$4,585,000.00 (Data available from 1/1/2013 forward) SUPN Insider Trading Activity - Frequently Asked Questions Who is on Supernus Pharmaceuticals' Insider Roster? The list of insiders at Supernus Pharmaceuticals includes Frank Mottola, Frederick M Hudson, Georges Gemayel, Jack A Khattar, Jonathan Rubin, Padmanabh P Bhatt, and Tami Tillotson Martin. Learn more on insiders at SUPN. What percentage of Supernus Pharmaceuticals stock is owned by insiders? 8.80% of Supernus Pharmaceuticals stock is owned by insiders. Learn more on SUPN's insider holdings. Which Supernus Pharmaceuticals insiders have been selling company stock? The following insiders have sold SUPN shares in the last 24 months: Frank Mottola ($585,924.30), Frederick M Hudson ($259,150.50), Georges Gemayel ($520,480.06), Jack A Khattar ($4,585,000.00), Jonathan Rubin ($36,292.05), Padmanabh P Bhatt ($1,631,404.11), and Tami Tillotson Martin ($644,694.65). How much insider selling is happening at Supernus Pharmaceuticals? Insiders have sold a total of 232,494 Supernus Pharmaceuticals shares in the last 24 months for a total of $8,262,945.67 sold. Which members of congress are trading Supernus Pharmaceuticals? Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Supernus Pharmaceuticals in the last year totaling $8,000. Supernus Pharmaceuticals Key ExecutivesMr. Jack A. Khattar (Age 63)Founder, President, CEO, Secretary & Director Compensation: $1.63MMr. Timothy C. Dec (Age 65)Senior VP & CFO Compensation: $635.43kDr. Padmanabh P. Bhatt Ph.D. (Age 67)Chief Scientific Officer & Senior VP of Intellectual Property Compensation: $594.14kMr. Frank Mottola (Age 52)Senior Vice President of Quality, GMP Operations & Information Technology Compensation: $490.87kDr. Jonathan Rubin M.D. (Age 63)MBA, Senior VP of Research & Development and Chief Medical Officer Compensation: $594.65kMr. Kevin T. Anderson (Age 62)Compliance Officer Dr. Todd Horich M.B.A.Ph.D., Senior Vice President of Marketing & Market AccessMr. Taylor RaifordSenior Vice President of SalesDr. Bryan A. Roecklein Ph.D.Senior Vice President of Corporate DevelopmentMs. Tami T. Martin Esq. (Age 69)R.N., Senior Vice President of Regulatory Affairs Compensation: $508.5k More Insider Trading Tools from MarketBeat Related Companies CORT Insider Selling JAZZ Insider Selling PRGO Insider Selling PCRX Insider Selling NKTR Insider Selling OMER Insider Selling ASMB Insider Selling CPIX Insider Selling LLY Insider Selling JNJ Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:SUPN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly tak...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.